A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
10.1210/jc.2012-1520
Saved in:
Main Authors: | Bible, K.C., Suman, V.J., Menefee, M.E., Smallridge, R.C., Molina, J.R., Maples, W.J., Karlin, N.J., Traynor, A.M., Kumar, P., Goh, B.C., Lim, W.-T., Bossou, A.R., Isham, C.R., Webster, K.P., Kukla, A.K., Bieber, C., Burton, J.K., Harris, P., Erlichman, C. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/126461 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
by: Bible, K.C., et al.
Published: (2016) -
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
by: Bible, K.C., et al.
Published: (2016) -
Combined temozolomide and radiation as an initial treatment for anaplastic glioma
by: Tham, C.K., et al.
Published: (2016) -
Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma
by: Davids, M., et al.
Published: (2011) -
Anaplastic large cell lymphoma of the palate: A case report
by: P. Lapthanasupkul, et al.
Published: (2020)